Impact of complex chronic diseases and life-limiting condition status on paediatric hospitalization: observational study
- PMID: 40447966
- DOI: 10.1007/s00431-025-06227-0
Impact of complex chronic diseases and life-limiting condition status on paediatric hospitalization: observational study
Abstract
Children with medical complexity (CMC) and life-limiting conditions (LLCs) have a high utilization of healthcare resources. This study aims to assess the impact of CMC and LLC on hospitalization in the Basque Public Health System (BPHS) and to compare CMC to LLC to characterize inpatient health utilization. This is a retrospective observational study including all admissions of paediatric patients (< 19 years) to the BPHS during the period 2018-2020. The Pediatric Medical Complexity Algorithm and the Hain Directory of Life-Limiting Conditions were used to identify children with complex chronic diseases (C-CDs) and LLCs, respectively. Inpatient health utilization and in-hospital mortality of patients with C-CD and LLC were compared to those without these conditions. A total of 34,555 admissions were recorded for 26,196 patients during the study period. Patients with C-CD and LLC accounted for 15.4% and 14.4% of these admissions, respectively. Patients with LLC were more likely to require respiratory or hemodynamic support and device placement than patients with C-CD. Children with LLC and C-CD exhibited a higher frequency and length of stay of both general and ICU admissions than those without these conditions. Eight out of ten patients who died during admission had C-CD and/or LLC, with a higher probability of in-hospital death among patients with LLC.
Conclusion: A considerable proportion of admissions among children was attributed to patients with C-CD and LLC. Both exhibited substantial utilization of hospital resources and high in-hospital mortality, being more pronounced among patients with LLC. Further studies focused on cost/expenditures are needed within a publicly insured health system.
What is known: • Children with medical complexity (CMC) consume a lot of healthcare resources, and their in-hospital mortality is high. There are several ways to identify CMC in health datasets. Both children with chronic complex disease (C-CD) and life-limiting conditions (LLC) are CMC.
What is new: • There is an important overlap between children classified as having C-CD and those with LLC. Both groups exhibited substantial utilization of hospital resources and high in-hospital mortality, being more pronounced among patients with LLC.
Keywords: Chronic disease; Hospital mortality; Hospitalized children; Paediatrics; Palliative care.
© 2025. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Conflict of interest statement
Declarations. Ethical approval: The Research Ethics Committee of the Basque Country approved the present study (CEI code 01/2022/PI2021216). We conducted this study according to international standards for epidemiological studies, as outlined in the International Guidelines for the Ethical Review of Epidemiological Studies and the Spanish Society of Epidemiology’s recommendations on ethical aspects of epidemiological research. Competing interest: The authors declare no competing interests.
Similar articles
-
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320. Health Technol Assess. 2001. PMID: 12065068
-
Home treatment for mental health problems: a systematic review.Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150. Health Technol Assess. 2001. PMID: 11532236
-
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3. Cochrane Database Syst Rev. 2022. PMID: 35593186 Free PMC article.
-
Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.Health Technol Assess. 2006 Aug;10(28):iii-iv, xi-xiv, 1-183. doi: 10.3310/hta10280. Health Technol Assess. 2006. PMID: 16904047
-
Transition of care for adolescents from paediatric services to adult health services.Cochrane Database Syst Rev. 2016 Apr 29;4(4):CD009794. doi: 10.1002/14651858.CD009794.pub2. Cochrane Database Syst Rev. 2016. PMID: 27128768 Free PMC article.
References
-
- Yamada H, Ohno K, Shiota M, Togawa M, Utsunomiya Y, Akaboshi S, Tsuchie H, Okada T, Oguri M, Higami S, Noma H, Maegaki Y (2020) Prevalence and clinical characteristics of children with medical complexity in Tottori Prefecture, Japan: a population-based longitudinal study. Brain Dev 42:747–755. https://doi.org/10.1016/j.braindev.2020.06.008 - DOI - PubMed
-
- Cohen E, Patel H (2014) Responding to the rising number of children living with complex chronic conditions. Can Med Assoc J 186:1199–1200. https://doi.org/10.1503/cmaj.141036 - DOI
-
- Fraser LK, Gibson-Smith D, Jarvis S, Norman P, Parslow R (2020) “Make Every Child Count” Estimating current and future prevalence of children and young people with life-limiting conditions in the United Kingdom. https://www.togetherforshortlives.org.uk/resource/make-every-child-count/ . Accessed 29 May 2025
-
- Johaningsmeir SA, Colby H, Krauthoefer M, Simpson P, Conceição SCO, Gordon JB (2015) Impact of caring for children with medical complexity and high resource use on family quality of life. J Pediatr Rehabil Med 8:75–82. https://doi.org/10.3233/PRM-150321 - DOI - PubMed
-
- Pérez-Ardanaz B, Gutiérrez-Rodríguez L, Pelaez-Cantero MJ, Morales-Asencio JM, Gómez-González A, García-Piñero JM, Lupiañez-Perez I (2024) Healthcare service use for children with chronic complex diseases: a longitudinal six-year follow-up study. J Pediatr Nurs 77:e132–e138. https://doi.org/10.1016/j.pedn.2024.04.001 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources